Breaking News
6 hours ago
Vaibhavi M.
NKGen Biotech appoints Alzheimer’s and FTD expert Dr. Bruce Miller to strengthen its neurodegeneration cell therapy strategy.
Vaibhavi M.
Medicus revises its LifeArc license for Teverelix, cutting royalties while preserving global development and commercial rights.
Vaibhavi M.
BioStem completes acquisition of BioTissue’s wound care business, adding Neox and Clarix to its regenerative medicine portfolio.
Vaibhavi M.
Greenwich LifeSciences receives FDA clearance to use its first commercial GP2 lot in the Phase III GLSI-100 study.
Vaibhavi M.